activity
20242026
collaborators
Showing 2026Show all

5 papers · 1 filter

stat.ME2026

Shape-Preserving Covariate Adjustment via Empirical Likelihood in Randomized Experiment

Zhilan Lou, Jun Shao, Yuhan Qian +4

Covariate adjustment improves estimation efficiency in randomized experiments, but standard calibration and augmentation methods, when applied to distribution or survival functions…

stat.ME2026

Bridging Balancing Weights and Augmentation in Covariate-adjusted Analyses with Time-to-Event Endpoints: Theory and Practical Recommendations

Baoshan Zhang, Yi Chen, Yu Du +1

Covariate adjustment improves the efficiency of treatment-effect analyses in randomized clinical trials, provided the adjustment targets the correct quantity. For time-to-event end…

stat.ME2026

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test

Zhilan Lou, Jun Shao, Ting Ye +3

We apply covariate adjustment to the Wincoxon two sample statistic and Wincoxon-Mann-Whitney test in comparing two treatments. The covariate adjustment through calibration not only…

stat.ME2026

Competing Risk Analysis in Cardiovascular Outcome Trials: A Simulation Comparison of Cox and Fine-Gray Models

Tuo Wang, Yu Du

Cardiovascular outcome trials commonly face competing risks when non-CV death prevents observation of major adverse cardiovascular events (MACE). While Cox proportional hazards mod…

stat.ME2026

Capturing Cumulative Disease Burden in Chronic Kidney Disease Outcome Trials: Area Under the Curve and Restricted Mean Time in Favor of Treatment Beyond Conventional Time-to-First Analysis

Jiren Sun, Tuo Wang, Yu Du

Chronic kidney disease (CKD) affects millions worldwide and progresses irreversibly through stages culminating in end-stage renal disease (ESRD) and death. Outcome trials in CKD tr…